Samjin Pharmaceuticals Co., Ltd. (KRX:005500)
South Korea · Delayed Price · Currency is KRW 18,970
-30 (-0.16%)
Last updated: Sep 9, 2025, 9:00 AM KST
Samjin Pharmaceuticals Market Cap
Samjin Pharmaceuticals has a market cap or net worth of 232.53 billion as of September 8, 2025. Its market cap has decreased by -2.40% in one year.
Market Cap
232.53B
Enterprise Value
n/a
Revenue
274.03B
Ranking
n/a
PE Ratio
10.98
Stock Price
18,970.00
Market Cap Chart
Since August 30, 1995, Samjin Pharmaceuticals's market cap has increased from 29.12B to 232.53B, an increase of 698.53%. That is a compound annual growth rate of 7.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 232.53B | 4.93% |
| Dec 30, 2024 | 221.61B | -19.69% |
| Dec 28, 2023 | 275.94B | -19.80% |
| Dec 29, 2022 | 344.07B | 5.06% |
| Dec 30, 2021 | 327.51B | -3.49% |
| Dec 30, 2020 | 339.34B | 9.22% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.38T |
| Celltrion | 37.45T |
| ALTEOGEN | 25.54T |
| Yuhan | 9,104.15B |
| SK Biopharmaceuticals | 8,575.30B |
| PharmaResearch | 7,013.01B |
| Peptron | 6,756.23B |
| LigaChem Biosciences | 5,523.68B |